Ilene Galinsky, BSN, MSN, ANP-C

home / authors / ilene-galinsky

Articles

Galinsky Breaks Down Venetoclax Symptom Management in AML

Galinsky Breaks Down Venetoclax Symptom Management in AML

Ilene Galinsky, BSN, MSN, ANP-C
July 11th 2022

Ilene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.

Ilene Galinsky Highlights Optimal Venetoclax Dosing Strategies in AML

Ilene Galinsky Highlights Optimal Venetoclax Dosing Strategies in AML

Ilene Galinsky, BSN, MSN, ANP-C
June 14th 2022

Ilene Galinsky, BSN, MSN, ANP-C, senior leukemia protocol research nurse practitioner at Dana-Farber Cancer Institute, underscores key prescribing considerations with venetoclax.

Ilene Galinsky, BSN

Ilene Galinsky Highlights Evolution of AML Treatment

Ilene Galinsky, BSN, MSN, ANP-C
April 28th 2022

Ilene Galinsky, BSN, MSN, ANP-C, senior leukemia protocol research nurse practitioner, at Dana Farber Cancer Institute, discusses how treatment for patients with acute myeloid leukemia has evolved in recent years.

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.